Conformational Propensity and Biological Studies of Proline Mutated LR Peptides Inhibiting Human Thymidylate Synthase and Ovarian Cancer Cell Growth
- J Med Chem. 2018 Aug 23;61(16):7374-7380. doi: 10.1021/acs.jmedchem.7b01699.
- 1. Department of Life Sciences , University of Modena and Reggio Emilia , Via Campi 103 , 41125 Modena , Italy.
- 2. Department of Biomedical Sciences, Metabolic and Neural Sciences , University of Modena and Reggio Emilia , Via Campi 287 , 41125 Modena , Italy.
- 3. Dipartimento di Scienze degli Alimenti e del Farmaco , Università di Parma , Parco Area delle Scienze 27/A , I-43124 Parma , Italy.
- 4. Pathological Anatomy , Via del Pozzo 71 , 41124 Modena , Italy.
- 5. Department of Chemical and Pharmaceutical Sciences , University of Ferrara , Via Luigi Borsari 46 , 44121 Ferrara , Italy.
- 6. LTTA (Laboratorio per le Tecnologie delle Terapie Avanzate) , Via Fossato di Mortara 17-19 , 44100 Ferrara , Italy.
LR and [d-Gln4]LR peptides bind the monomer-monomer interface of human Thymidylate Synthase and inhibit Cancer cell growth. Here, proline-mutated LR peptides were synthesized. Molecular dynamics calculations and circular dichroism spectra have provided a consistent picture of the conformational propensities of the [Pro n]-peptides. [Pro3]LR and [Pro4]LR show improved cell growth inhibition and similar intracellular protein modulation compared with LR. These represent a step forward to the identification of more rigid and metabolically stable peptides.